| 000 | 01239 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513120138.0 | ||
| 264 | 0 | _c19970718 | |
| 008 | 199707s 0 0 eng d | ||
| 022 | _a0889-857X | ||
| 024 | 7 |
_a10.1016/s0889-857x(05)70338-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGeorge, C S | |
| 245 | 0 | 0 |
_aHematologic complications of rheumatic disease therapies. _h[electronic resource] |
| 260 |
_bRheumatic diseases clinics of North America _cMay 1997 |
||
| 300 |
_a425-37 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnemia _xchemically induced |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadverse effects |
| 650 | 0 | 4 |
_aHematologic Diseases _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunocompromised Host |
| 650 | 0 | 4 |
_aLeukemia _xchemically induced |
| 650 | 0 | 4 |
_aLeukopenia _xchemically induced |
| 650 | 0 | 4 |
_aLymphoma _xchemically induced |
| 650 | 0 | 4 |
_aNeoplasms, Second Primary _xchemically induced |
| 650 | 0 | 4 |
_aRheumatic Diseases _xdrug therapy |
| 700 | 1 | _aLichtin, A E | |
| 773 | 0 |
_tRheumatic diseases clinics of North America _gvol. 23 _gno. 2 _gp. 425-37 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0889-857x(05)70338-0 _zAvailable from publisher's website |
| 999 |
_c9137661 _d9137661 |
||